Home / Cefroxadine / Japan
JP ATC J01DB11 · updated 2 Nov 2026
Cefroxadine shortage in Japan
Is there a Cefroxadine shortage in Japan?
Yes. As of 2 Nov 2026, 1 Cefroxadine product is reported short in Japan, the first since 22 Jan 2026. No return date has been given. Main reason: active ingredient shortage.
Not reported short in any other country we track. All countries.
Affected products in Japan
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| JP | オラスポア小児用ドライシロップ10% limited | Alfresa Pharma | 22 Jan 2026 | not given | Active ingredient shortage Raw material (active ingredient) supply problem |
Source
MHLW (Ministry of Health, Labour and Welfare), supply status of prescription medicines. Official list. Prescription products under limited shipment or supply suspension (delistings excluded); one row per product.